Literature DB >> 15381096

4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models.

K Eger1, M Hermes, K Uhlemann, S Rodewald, J Ortwein, M Brulport, A W Bauer, W Schormann, F Lupatsch, I B Schiffer, C K Heimerdinger, S Gebhard, C Spangenberg, D Prawitt, T Trost, B Zabel, C Sauer, B Tanner, H Kolbl, U Krugel, H Franke, P Illes, P Madaj-Sterba, E O Bockamp, T Beckers, J G Hengstler.   

Abstract

Since the pioneering work by Gossen and Bujard in 1992 demonstrating the usefulness of the Escherichia coli derived tet resistance operon for regulating gene expression a large collection of doxycycline-controlled transgenic mice has been established. Gene switching in eukaryotic tissue culture cells or mice requires administration of tetracycline, anhydrotetracycline or doxycycline to efficiently inactivate the transactivator protein tTA (TET-OFF system) or alternatively to activate the reverse transactivator protein rtTA (TET-ON system). However, the antibiotic activity of doxycycline can create an imbalance of the intestinal flora, resulting in diarrhoea and in a smaller number of animals in colitis. Previous studies reported that 4-epidoxycycline (4-ED), a hepatic metabolite of doxycycline, does not function as an antibiotic in mice. This gave us the idea that 4-ED might be useful for controlling gene expression in mice without the unwanted antibiotic side effect. To study the applicability of 4-ED for control of gene expression we used cell lines expressing the oncogene HER2 under control of tTA (TET-OFF) as well as rtTA (TET-ON). 4-ED and doxycycline were similarly efficient in switching on or -off HER2 expression. In vivo we used a conditional mouse model that allows switching off HER2 in tumor tissue. We show that (i) doxycycline, 7.5mg/ml in drinking water (used as a positive control), (ii) 4-ED, 7.5mg/ml in drinking water, (iii) 4-ED, 10mg/kg body weight, s.c., and (iv) anhydrotetracycline, 10mg/kg, s.c. (used as a second positive control), were similarly efficient. Using mice with tumor volumes of 1.6cm(3) all four schedules led to a tumor remission of more than 95% within 7 days. In conclusion, 4-ED is similarly efficient as doxycycline to control gene expression in vitro and in mice. Since 4-ED lacks the antibiotic activity of doxycycline it may help to avoid adverse side effects and selection of resistant bacteria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381096     DOI: 10.1016/j.bbrc.2004.08.187

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Development of single-vector Tet-on inducible systems with high sensitivity to doxycycline.

Authors:  Jiun-Shuan Chao; Chun-Chieh Chao; Chu-Li Chang; Yi-Rong Chiu; Chiun-Jye Yuan
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

Review 2.  A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.

Authors:  Abdelwahed Chtarto; Olivier Bockstael; Terence Tshibangu; Olivier Dewitte; Marc Levivier; Liliane Tenenbaum
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

3.  IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.

Authors:  Jerod A Skyberg; Theresa Thornburg; Irina Kochetkova; William Layton; Gayle Callis; MaryClare F Rollins; Carol Riccardi; Todd Becker; Sarah Golden; David W Pascual
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

4.  Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury.

Authors:  T Kucharzik; J T Hudson; A Lügering; J A Abbas; M Bettini; J G Lake; M E Evans; T R Ziegler; D Merlin; J L Madara; I R Williams
Journal:  Gut       Date:  2005-06-29       Impact factor: 23.059

5.  Tracking of human cells in mice.

Authors:  Wiebke Schormann; Friedrich J Hammersen; Marc Brulport; Matthias Hermes; Alexander Bauer; Claudia Rudolph; Markus Schug; Thomas Lehmann; Andreas Nussler; Hendrik Ungefroren; James Hutchinson; Fred Fändrich; Jörg Petersen; Karsten Wursthorn; Martin R Burda; Oliver Brüstle; Kannan Krishnamurthi; Marc von Mach; Jan G Hengstler
Journal:  Histochem Cell Biol       Date:  2008-04-19       Impact factor: 4.304

6.  Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease.

Authors:  Ashok K Chaturvedi; Anna L Lazzell; Stephen P Saville; Floyd L Wormley; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

7.  Doxycycline induces dysbiosis in female C57BL/6NCrl mice.

Authors:  Felicia D Duke Boynton; Aaron C Ericsson; Mayu Uchihashi; Misha L Dunbar; J Erby Wilkinson
Journal:  BMC Res Notes       Date:  2017-11-29

Review 8.  In vivo gene regulation using tetracycline-regulatable systems.

Authors:  Knut Stieger; Brahim Belbellaa; Caroline Le Guiner; Philippe Moullier; Fabienne Rolling
Journal:  Adv Drug Deliv Rev       Date:  2009-04-23       Impact factor: 15.470

9.  IL-6 can singlehandedly drive many features of frailty in mice.

Authors:  Mladen Jergović; Heather L Thompson; Christine M Bradshaw; Sandip Ashok Sonar; Arveen Ashgar; Niels Mohty; Bellal Joseph; Mindy J Fain; Kristan Cleveland; Rick G Schnellman; Janko Nikolich-Žugich
Journal:  Geroscience       Date:  2021-02-24       Impact factor: 7.713

10.  Development of a liver-specific Tet-off AAV8 vector for improved safety of insulin gene therapy for diabetes.

Authors:  Shu Uin Gan; Zhenying Fu; Kian Chuan Sia; Oi Lian Kon; Roy Calne; Kok Onn Lee
Journal:  J Gene Med       Date:  2019-01-20       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.